Argentina-Alzheimer’s disease neuroimaging initiative (Arg-ADNI): Neuropsychological evolution profile after one-year follow up

2Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

Abstract

The Argentina-Alzheimer’s disease neuroimaging initiative (Arg-ADNI) study is a longitudinal prospective cohort of 50 participants at a single institution in Buenos Aires, Argentina. Longitudinal assessments on a neuropsychological test battery were performed on 15 controls, 24 mild cognitive impairment (MCI) patients and 12 Alzheimer’s disease (AD) dementia patients. In our study population, there was a high prevalence of positive AD biomarkers in the AD group, 92.3% (12/13); and a low prevalence in the normal controls, 20%; almost half (48%) of the patients diagnosed with MCI had positive amyloid detection. After a one year, the significant differences found at baseline on neuropsychological testing were similar at the follow-up assessment even though the AD group had significantly altered its functional performance (FAQ and CDR). The exception was semantic fluency, which showed greater impairment between the AD group and MCI and normal controls respectively. For these tests, the addition of AD biomarkers as a variable did not significantly alter the variations previously found for the established clinical group’s model. Finally, the one-year conversion rate to dementia was 20% in the MCI cohort.

Cite

CITATION STYLE

APA

Méndez, P. C., Calandri, I., Nahas, F., Russo, M. J., Demey, I., Martín, M. E., … Sevlever, G. (2018). Argentina-Alzheimer’s disease neuroimaging initiative (Arg-ADNI): Neuropsychological evolution profile after one-year follow up. Arquivos de Neuro-Psiquiatria, 76(4), 231–240. https://doi.org/10.1590/0004-282x20180025

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free